Atlas Trials

A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients

Clinical trial NCT02648906 · UNKNOWN

Trial details

NCT number
NCT02648906
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2015-07-01
Primary completion
2018-11-01
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.